Polymer degradation and in vitro release of a model protein from poly(D,L-lactide-co-glycolide) nano- and microparticles

被引:408
作者
Panyam, J
Dali, MA
Sahoo, SK
Ma, WX
Chakravarthi, SS
Amidon, GL
Levy, RJ
Labhasetwar, V
机构
[1] Univ Nebraska, Med Ctr, Dept Pharmaceut Sci, Omaha, NE 68198 USA
[2] Univ Michigan, Coll Pharm, Ann Arbor, MI 48109 USA
[3] Univ Penn, Sch Med, Dept Pediat, Childrens Hosp Philadelphia,Div Cardiol, Philadelphia, PA 19104 USA
[4] Univ Nebraska, Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA
关键词
sustained release; biodegradable polymers; drug delivery; particle size; polyvinyl alcohol;
D O I
10.1016/S0168-3659(03)00328-6
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The objective of the study was to investigate the effect of particle size of nano- and rnicroparticles formulated from poly(D,L-lactide-co-glycolide) (50:50 PLGA) on polymer degradation and protein release. Since the surface area to volume ratio is inversely proportional to the particle size, it is hypothesized that the particle size would influence the polymer degradation as well as the release of the encapsulated protein. PLGA nano- and microparticles of approximate mean diameters of 0.1, 1 and 10 mum, containing bovine serum albumin as a model protein, were formulated using a multiple water-in-oil-in-water emulsion solvent evaporation technique. These particles were incubated at 37 degreesC in phosphate-buffered saline (pH 7.4, 154 mM) and the particles were characterized at various time points for molecular weight of polymer, surface-associated polyvinyl alcohol content (PVA), and the particle surface topology using scanning electron microscopy. The supernatants from the above study were analyzed for the released protein and PVA content. Polymer degradation was found to be biphasic in both nano- and microparticles, with an initial rapid degradation for 20-30 days followed by a slower degradation phase. The 0.1 mum diameter nanoparticles demonstrated relatively higher polymer degradation rate (P<0.05) during the initial phase as compared to the larger size microparticles (first order degradation rate constants of 0.028 day(-1), 0.011 day(-1) and 0.018 day(-1) for 0.1, 1 and 10 mum particles, respectively), however the degradation rates were almost similar (0.008 to 0.009 day(-1)) for all size particles during the later phase. All size particles maintained their structural integrity during the initial degradation phase; however, this was followed by pore formation, deformation and fusion of particles during the slow degradation phase. Protein release from 0.1 and 1 mum particles was greater than that from 10 mum size particles. In conclusion, the polymer degradation rates in vitro were not substantially different for different size particles despite a 10- and 100-fold greater surface area to volume ratio for 0.1 pm size nanoparticles as compared to 1 and 10 mum size microparticles, respectively. Relatively higher amounts of the surface-associated PVA found in the smaller-size nanoparticles (0.1 mum) as compared to the larger-size microparticles could explain some of the observed degradation results with different size particles. (C) 2003 Elsevier B.V. All rights reserved.
引用
收藏
页码:173 / 187
页数:15
相关论文
共 24 条
[1]   Biodegradation and biocompatibility of PLA and PLGA microspheres [J].
Anderson, JM ;
Shive, MS .
ADVANCED DRUG DELIVERY REVIEWS, 1997, 28 (01) :5-24
[2]   The control of protein release from poly(DL-lactide co-glycolide) microparticles by variation of the external aqueous phase surfactant in the water-in oil-in water method [J].
Coombes, AGA ;
Yeh, MK ;
Lavelle, EC ;
Davis, SS .
JOURNAL OF CONTROLLED RELEASE, 1998, 52 (03) :311-320
[3]   Protein delivery from poly(lactic-co-glycolic acid) biodegradable microspheres: release kinetics and stability issues [J].
Crotts, G ;
Park, TG .
JOURNAL OF MICROENCAPSULATION, 1998, 15 (06) :699-713
[4]   The mechanism of uptake of biodegradable microparticles in Caco-2 cells is size dependent [J].
Desai, MP ;
Labhasetwar, V ;
Walter, E ;
Levy, RJ ;
Amidon, GL .
PHARMACEUTICAL RESEARCH, 1997, 14 (11) :1568-1573
[5]   Gastrointestinal uptake of biodegradable microparticles: Effect of particle size [J].
Desai, MP ;
Labhasetwar, V ;
Amidon, GL ;
Levy, RJ .
PHARMACEUTICAL RESEARCH, 1996, 13 (12) :1838-1845
[6]   Influence of particle size and dissolution conditions on the degradation properties of polylactide-co-glycolide particles [J].
Dunne, M ;
Corrigan, OI ;
Ramtoola, Z .
BIOMATERIALS, 2000, 21 (16) :1659-1668
[7]   HYDROLYTIC DEGRADATION OF DEVICES BASED ON POLY(DL-LACTIC ACID) SIZE-DEPENDENCE [J].
GRIZZI, I ;
GARREAU, H ;
LI, S ;
VERT, M .
BIOMATERIALS, 1995, 16 (04) :305-311
[8]   Influence of formulation variables on the in-vitro release of albumin from biodegradable microparticulate systems [J].
Igartua, M ;
Hernandez, RM ;
Esquisabel, A ;
Gascon, AR ;
Calvo, MB ;
Pedraz, JL .
JOURNAL OF MICROENCAPSULATION, 1997, 14 (03) :349-356
[9]   Assessment of protein release kinetics, stability and protein polymer interaction of lysozyme encapsulated poly (D,L-lactide-co-glycolide) microspheres [J].
Jiang, G ;
Woo, BH ;
Kang, FR ;
Singh, J ;
DeLuca, PP .
JOURNAL OF CONTROLLED RELEASE, 2002, 79 (1-3) :137-145
[10]   Biodegradable nanoparticles for drug and gene delivery to cells and tissue [J].
Panyam, J ;
Labhasetwar, V .
ADVANCED DRUG DELIVERY REVIEWS, 2003, 55 (03) :329-347